1-20 of 55
Nausheen Ahmed
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Axi-cel outcomes among non-Hispanic Black patients

Clinical Trials & Observations
William Wesson, Nausheen Ahmed
Journal: Blood
Blood (2024) 143 (26): 2681–2682.
https://doi.org/10.1182/blood.2024024959
Published: 2024
Journal Articles

Outcomes of Vdpace for Relapsed/Refractory Multiple Myeloma in the Era of Daratumumab Based Therapy

Priyanka Venkatesh, Ghena Khasawneh, Hamza Hashmi, Omar Alkharabsheh, Barry Paul, Barry S. Skikne, Zahra Mahmoudjafari, Nausheen Ahmed, Al-Ola Abdallah, Shebli Atrash
Journal: Blood
Blood (2023) 142 (Supplement 1): 1971.
https://doi.org/10.1182/blood-2023-188117
Published: 2023
Journal Articles

Real World Outcomes with Idecabtagene Vicleucel (Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma

Surbhi Sidana, Nausheen Ahmed, Othman S Akhtar, Michael Heim, Ruta Brazauskas, Doris K. Hansen, Christopher Ferreri, Ciara Louise L. Freeman, Aimaz Afrough, Larry D. Anderson, Jr., Binod Dhakal, Devender Dhanda, Lohith Gowda, Hamza Hashmi, Melanie Harrison, Amani Kitali, Sayeef Mirza, Jinalben Patel, Pallavi Patwardhan, Saad Z Usmani, Krina K. Patel, Siddhartha Ganguly, Marcelo Pasquini
Journal: Blood
Blood (2023) 142 (Supplement 1): 1027.
https://doi.org/10.1182/blood-2023-181762
Published: 2023
Journal Articles

Lisocabtagene Maraleucel in Relapsed/Refractory Large B-Cell Lymphoma: Real World Analysis from the Cell Therapy Consortium

Peter A Riedell, Connor Grady, Loretta J. Nastoupil, Alejandro Luna, Nausheen Ahmed, Richard T Maziarz, Marie Hu, Jamie Brower, Wei-Ting Hwang, Stephen J Schuster, Andy Chen, Olalekan O. Oluwole, Veronika Bachanova, Joseph P McGuirk, Miguel-Angel Perales, Michael R. Bishop, David L. Porter
Journal: Blood
Blood (2023) 142 (Supplement 1): 617.
https://doi.org/10.1182/blood-2023-184862
Published: 2023
Journal Articles

Use of Eltrombopag for Post-CAR T Cytopenias: A Multi-Institutional Experience

William Wesson, Nausheen Ahmed, James A Davis, Mary McGann, Aliya Rashid, Carine Tabak, Emerson Logan, Jose Marchena-Burgos, Maggie Nelson, Leyla Shune, Marc S. Hoffmann, Al-Ola Abdallah, Hamza Hashmi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2136.
https://doi.org/10.1182/blood-2023-181283
Published: 2023
Journal Articles

Comparison of Biosimilar Filgrastim (Nivestym) Versus Originator Filgrastim (Neupogen) for Peripheral Blood Stem Cell Mobilization for Allogeneic Hematopoietic Stem Cell Transplantation

Moazzam Shahzad, Joe S. Al-Ramahi, Muhammad Kashif Amin, Muhammad Fareed Khalid, Shaun DeJarnette, Zahra Mahmoudjafari, Maggie Nelson, Riley Hastings, Haitham Abdelhakim, Forat Lutfi, Nausheen Ahmed, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq
Journal: Blood
Blood (2023) 142 (Supplement 1): 3523.
https://doi.org/10.1182/blood-2023-185652
Published: 2023
Journal Articles

The Glass Wall: Gendered Authorship Disparities in in CD 19 and BCMA CAR-T Clinical Trials for Lymphoma and Myeloma

Aroog Khaliq, William Wesson, Emerson Logan, Carine Tabak, Aliya Rashid, Razan Mansour, Muhammad Umair Mushtaq, Joseph P McGuirk, Hamza Hashmi, Mehdi Hamadani, Al-Ola Abdallah, Nausheen Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 2344.
https://doi.org/10.1182/blood-2023-179409
Published: 2023
Journal Articles

Impact of Frailty on Outcomes after CAR T-Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma

James A Davis, Danai Dima, Nausheen Ahmed, Shaun DeJarnette, Joseph P McGuirk, Jack Khouri, Jason Valent, Faiz Anwer, Al-Ola Abdallah, Hamza Hashmi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3503.
https://doi.org/10.1182/blood-2023-179981
Published: 2023
Journal Articles

Comparative Effectiveness of Axicabtagene Ciloleucel Vs Historical Standard-of-Care in Patients with Relapsed or Refractory Follicular Lymphoma: An Analysis of CIBMTR and SCHOLAR-5 Data

Swetha Kambhampati, Hai-Lin Wang, Jiali Yan, Alex F. Herrera, Matthew J. Frank, Leslie L. Popplewell, Nausheen Ahmed, Yi Lin, Frederick L. Locke, Paola Ghione, John G. Gribben, Timothy Best, Christine Fu, Sara Beygi, Markqayne D Ray, John Bian, Zhen-Huan Hu, Fang Sun, Marcelo Pasquini, Caron A. Jacobson
Journal: Blood
Blood (2023) 142 (Supplement 1): 2121.
https://doi.org/10.1182/blood-2023-178629
Published: 2023
Journal Articles

Trends in Access to Cellular Therapies in Multiple Myeloma (TACTUM): Perspectives of Treating Versus Referring Physicians

Rawan Atallah, Md Saiful Islam Saif, Danai Dima, Anuj Shrestha, Faiz Anwer, Muhammad Umair Mushtaq, Forat Lutfi, Leyla Shune, Hamza Hashmi, Siddhartha Ganguly, Joseph P McGuirk, Shebli Atrash, Al-Ola Abdallah, Rahul Banerjee, Nausheen Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 6678.
https://doi.org/10.1182/blood-2023-181218
Published: 2023
Journal Articles

Global Access to Multiple Myeloma Medications (GLAMM-2 Study): Access and Barriers to Chemoimmunotherapies and Transplant

Aytaj Mammadzadeh, Yara Shatnawi, Rawan Atallah, Benlazar Mohamed, Nihar Desai, Shahrukh K Hashmi, Thiago Xavier Carneiro, Hira Shaikh, Christopher Strouse, Rakesh Popat, Zahra Mahmoudjafari, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 4727.
https://doi.org/10.1182/blood-2023-185151
Published: 2023
Journal Articles

Outcomes after Bone Marrow Versus Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

Joe S. Al-Ramahi, Moazzam Shahzad, Muhammad Kashif Amin, Shaun DeJarnette, Maggie Nelson, Forat Lutfi, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq
Journal: Blood
Blood (2023) 142 (Supplement 1): 7028.
https://doi.org/10.1182/blood-2023-185209
Published: 2023
Journal Articles

Toxicity and Efficacy Outcomes of Teclistamab in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Above the Age of 70 Years: A Multicenter Study

Danai Dima, Aishwarya Sannareddy, Nausheen Ahmed, James A Davis, Hira Shaikh, Zahra Mahmoudjafari, Marissa Duco, Jack Khouri, Gurbakhash Kaur, Jonathan Lochner, Faiz Anwer, Aimaz Afrough, Jason Valent, Hamza Hashmi, Al-Ola Abdallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 3330.
https://doi.org/10.1182/blood-2023-180458
Published: 2023
Journal Articles

Efficacy of Siltuximab for Chimeric Antigen Receptor T-Cell Therapy Toxicities - a Multicenter Retrospective Analysis

Amneet K Bajwa, Qiuhong Zhao, Marcus Johannes Geer, Agrima Mian, Chenyu Lin, David Frame, James Westholder, Justin Tossey, Monalisa Ghosh, Ahmed Galal, Nausheen Ahmed, Joseph E. Maakaron, Nathan Denlinger, Marcos de Lima, Narendranath Epperla, Paolo F. Caimi, Timothy Voorhees
Journal: Blood
Blood (2023) 142 (Supplement 1): 4502.
https://doi.org/10.1182/blood-2023-179620
Published: 2023
Journal Articles

BCMA Re-Emergence As a Prognostic Indicator of Clinical Relapse after Chimeric Antigen Receptor T-Cell Therapy (CART) in Multiple Myeloma

Aliya Rashid, William Wesson, Forat Lutfi, Muhammad Umair Mushtaq, Joseph P McGuirk, Al-Ola Abdallah, Wei Cui, Nausheen Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 6801.
https://doi.org/10.1182/blood-2023-182126
Published: 2023
Journal Articles

Balancing Monitoring and Access: Optimal Duration of Monitoring for CD19 and BCMA CART Recipients for Lymphoma and Myeloma

William Wesson, Aliya Rashid, Md Saiful Islam Saif, Emerson Logan, Carine Tabak, Mary McGann, James A Davis, Liz Hazlett, Forat Lutfi, Muhammad Umair Mushtaq, Al-Ola Abdallah, Marc S. Hoffmann, Hamza Hashmi, Joseph P McGuirk, Mehdi Hamadani, Nausheen Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 6914.
https://doi.org/10.1182/blood-2023-182872
Published: 2023
Journal Articles

Vdpace As Salvage Therapy in Triple Class Relapse/Refractory Multiple Myeloma

Priyanka Venkatesh, Sara Shatnawi, Yara Shatnawi, Hira Shaikh, Christopher Strouse, Shebli Atrash, Muhammad Umair Mushtaq, Nausheen Ahmed, Zahra Mahmoudjafari, Al-Ola Abdallah, Leyla Shune
Journal: Blood
Blood (2023) 142 (Supplement 1): 6694.
https://doi.org/10.1182/blood-2023-187652
Published: 2023
Journal Articles

Real-World Safety and Efficacy of Teclistamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma

Danai Dima, James A Davis, Nausheen Ahmed, Aishwarya Sannareddy, Hira Shaikh, Zahra Mahmoudjafari, Jack Khouri, Gurbakhash Kaur, Christopher Strouse, Jason Valent, Larry D. Anderson, Jr., Faiz Anwer, Al-Ola Abdallah, Hamza Hashmi
Journal: Blood
Blood (2023) 142 (Supplement 1): 91.
https://doi.org/10.1182/blood-2023-180421
Published: 2023
Journal Articles

Efficacy and Safety of Daratumumab, Pomalidomide and Dexamethasone Compared to Daratumumab, Carfilzomib and Dexamethasone in Daratumumab-Naïve Relapsed Multiple Myeloma: Multicenter Real-World Experience

Razan Mansour, James A Davis, Megan Minchak, Rawan Atallah, Md Saiful Islam Saif, Emerson Logan, Carine Tabak, Aliya Rashid, Danai Dima, Nausheen Ahmed, Al-Ola Abdallah, Hamza Hashmi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3361.
https://doi.org/10.1182/blood-2023-179661
Published: 2023
Journal Articles

The GLAMM1 Study - Global Access to Myeloma Medications: Potential Barriers to Chimeric Antigen Receptors (CART) and T-Cell-Engaging Bispecific Antibodies (TCE) Globally

Rawan Atallah, Yara Shatnawi, Aytaj Mammadzadeh, Shahrukh K Hashmi, Shabeeha K Rana, Muhammad Umair Mushtaq, Benlazar Mohamed, Nihar Desai, Thiago Xavier Carneiro, Rakesh Popat, Joseph P McGuirk, Shebli Atrash, Zahra Mahmoudjafari, Al-Ola Abdallah, Nausheen Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 3327.
https://doi.org/10.1182/blood-2023-179050
Published: 2023